Chronic rhinosinusitis (CRS) is a surprisingly common but under-recognized disease that affects nearly one billion people ...

The first head-to-head randomized clinical trial to compare biologics in severe chronic rhinosinusitis with nasal polyps ...

An FDA Decision for Amgen and AstraZeneca’s Tezspire in CRSwNP is slated for October 19: Why Approval Looks Likely.

New research from BIDMC and Stanford reveals how nasal polyps form in chronic sinusitis, offering hope for improved care and treatment options. Read more.

Tezspire (tezepelumab) has received a positive opinion from the CHMP for the treatment of chronic rhinosinusitis with nasal ...

Scientists Uncover the "Cellular Conspiracy" Behind Chronic Sinus DiseaseBOSTON — Chronic rhinosinusitis (CRS) is a surprisingly common but ...

​Amgen Inc. (NASDAQ: AMGN) is one of the Most Undervalued Growth Stocks to Buy According to Hedge Funds. On September 22, ...

You're five times more likely to contract bowel cancer if two very particular factors are present, according to a new ...

AstraZeneca and Amgen’s Tezspire (tezepelumab) has been recommended for approval in the European Union (EU) for the treatment of adult patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

A new study reveals that popular low-carb, low-fiber diets may significantly increase the risk of colorectal cancer, ...

Their life cycle can repeat many times, and in perfect conditions, these jellyfish could avoid aging altogether.

“Screening allows us to detect cancer early. Colorectal cancer often begins with small growths in the intestine called polyps. Each polyp has a 30 to 40 percent chance of developing into cancer. If we ...